Allied Market Research published a report, titled, “Elastomer Infusion Pump Market by Product (Continuous Rate Pumps, Variable Rate Pumps), Application (Pain Management, Infection Management, Chemotherapy, and Others), and End User (Hospitals and Clinics, Ambulatory Care, and Home Care): Global Opportunity Analysis and Industry Forecast, 2019–2026.” According to the report, the global elastomer infusion pump industry generated $533.8 million in 2018 and is expected to hit $745.1 million by 2026, registering a CAGR of 4.2% from 2019 to 2026.
Drivers, restraints, and opportunities
Increase in burden on hospitals to reduce healthcare costs, emergence of novel elastomer infusion pumps, and user-friendly nature of the same fuel the growth of the global elastomer infusion pump market. On the other hand, poor demand in under-developed countries restrains the growth to some extent. However, developments in emerging countries are expected to create a number of opportunities in the industry.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6323
The continuous red pumps segment to dominate by 2026
Based on product, the continuous red pumps segment accounted for nearly three-fifths of the global elastomer infusion pump market share in 2018, and is expected to rule the roost by the end of 2026. Increase in demand for continuous rate elastomeric pumps, their ability to heal in chronic diseases, rise in adoption of elastomer infusion pump for post-operative pain management, and surge in application in cancer treatment across the globe Simultaneously, the variable rate pumps segment would showcase the fastest CAGR of 4.8% during the study period.
The pain management segment to lead the trail during the study period
Based on application, the pain management segment held the highest share in 2018, garnering one-third of the global elastomer infusion pump market. The fact that it helps maintain analgesia and drugs plasma level stability in order to control acute pain has boosted the growth of the segment. Simultaneously, the chemotherapy segment would cite the fastest CAGR of 5.4% throughout the forecast period. This is because chemotherapy is often used as an adjuvant to other therapeutic modalities such as radiation therapy and surgery.
North America generated the major share in 2018
Based on geography, North America contributed to more than two-fifths of the global elastomer infusion pump market revenue in 2018, and is anticipated to retain its dominance during the estimated period. Rise in demand for elastomer infusion pumps, presence of advanced healthcare facilities with trained medical professionals, and surge in number of R&D centers have propelled the market in this province. The region across Asia-Pacific, on the other hand, would grow at the fastest CAGR of 5.9% by 2026. Increase in prevalence of chronic diseases in various countries in the region, surge in demand for elastomer infusion pump products, rise in number of small and mid-sized hospitals have driven the growth.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6323
Leading market players
- Baxter International Inc.
- Pfm Medical Ag
- Halyard Health
- Heka Healthcare
- Pfizer Inc. (Hospira Inc.)
- Nipro Medical Corporation (Nipro Medical Europe NV)
- PROMECON GmbH
- B Braun Melsungen Ag
- Palex Medical SA
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
